It is a pharma private limited company based in Jaipur, Rajasthan, India, established in 2008.
2008 | Jaipur, Rajasthan, India | ActiveCuro Prime Pharmax Private Limited, a active private limited company, was established on 17 January 2008 in Jaipur, Rajasthan, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232RJ2008PTC025682. Registered under ROC Roc Jaipur. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.90 M.
It upholds a compliant status. Its leadership includes Sanjay Chamria (Director), Kushagar Chamaria (Director), Ajay Gupta (Director). Past directors included Sunil Gupta, Atish Kumar, Vinu Mitruka. It holds ₹1.20 M open charges and ₹2.60 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at G-1, Plot No. 802 Rani Sati Nagar, Bansi Path, Nirman Naga, R, Jaipur, Rajasthan, 302019.
U24232RJ2008PTC025682
025682
17 January 2008
₹3.00 M
₹2.90 M
Roc Jaipur
Unlisted
Active
Explore comprehensive insights into Curo Prime Pharmax Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjay Chamria | Director | 03 Apr 2010 | Current |
| Kushagar Chamaria | Director | 28 May 2022 | Current |
| Ajay Gupta | Director | 06 May 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 20 Mar 2013 | Past |
| Pramod Abcsdd | Director | 24 Aug 2011 | Past |
| Pramod Abcsdd | Director | 20 Mar 2013 | Past |
| Pramod Abcsdd | Director | 03 Jun 2022 | Past |
| Pramod Abcsdd | Director | 24 Aug 2011 | Past |
| Pramod Abcsdd | Director | 07 Sep 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curo Prime Pharmax Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.93% increase. The company also saw a substantial improvement in profitability, with a 372.3% increase in profit. The company's net worth moved up by a moderate rise of 8%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Curo Prime Pharmax had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹2,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Dec 2023 | Others | ₹1.20 M | Open |
| 23 Jul 2021 | Hdfc Bank Limited | ₹0.70 M | Satisfied |
| 30 Aug 2019 | Others | ₹0.90 M | Satisfied |
| 06 Feb 2017 | Others | ₹1.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Curo Prime Pharmax, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curo Prime Pharmax, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curo Prime Pharmax's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 30 Aug 2019 via Charge ID 100287519 with Others was fully satisfied on 10 Oct 2024. was recorded as a recent event.
Progress on A charge registered on 23 Jul 2021 via Charge ID 100464696 with Hdfc Bank Limited was fully satisfied on 09 Oct 2024. was documented.
A charge registered on 06 Feb 2017 via Charge ID 100077494 with Others was fully satisfied on 09 Oct 2024. was recorded as a recent event.
Progress on Curo Prime Pharmax Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Curo Prime Pharmax Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jaipur. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 1.20 M with Charge ID 100844491 was registered on 28 Dec 2023. was documented.
The CIN of Curo Prime Pharmax Private Limited is U24232RJ2008PTC025682.
Curo Prime Pharmax Private Limited is headquartered at G-1, Plot No. 802 Rani Sati Nagar, Bansi Path, Nirman Naga, R, Jaipur, Rajasthan, 302019.
Curo Prime Pharmax Private Limited was incorporated on 17 January 2008.
The current directors of Curo Prime Pharmax Private Limited are
The primary industry of Curo Prime Pharmax Private Limited is Pharma.
Curo Prime Pharmax Private Limited is unlisted.
The authorized capital of Curo Prime Pharmax Private Limited is ₹3.00 M, and the paid-up capital is ₹2.90 M.
The compliance status of Curo Prime Pharmax Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX